Breast cancer (BC) is the most frequently diagnosed cancer in women and the leading
cause of death for women worldwide. Conventional clinical treatment of BC entails surgery …

Simple Summary Internationally, in women, breast cancer (BC) is the most common cancer
type and is the leading cause of cancer-related death. There are two main histological …

Chemoresistance is one of the major challenges for the breast cancer treatment. Owing to its
heterogeneous nature, the chemoresistance mechanisms of breast cancer are complicated …

Breast cancer (BC), an intricate and highly heterogeneous disorder, has presently afflicted
2.09 million females globally. Chemoresistance remains a paramount challenge in the …

Our understanding of breast cancer and its therapeutic approach has improved greatly due
to the advancement of molecular biology in recent years. Clinically, breast cancers are …

Breast Cancer (BC) is a molecular heterogeneous disease and patients with similar clinico-
pathological characteristics often display different response to treatment. Cellular processes …

Breast cancer is the most prevalent cancer in women, worldwide. Thus, it has attained the
number one spot as the most diagnosed cancer in most regions across the world. It is also …

The incidence of breast cancer has increased over the past decades making it the most
common cancer in females worldwide. Multidrug resistance (MDR) has been one of the …

Breast cancer (BC) affects over 250,000 women in the US each year. Drug-resistant cancer
cells are responsible for most breast cancer fatalities. Scientists are developing novel …

Breast cancer is the most common type of cancer found in women and today represents a
significant challenge to public health. With the latest breakthroughs in molecular biology and …